Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.

A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston. 

The update includes multiple new algorithms designed to improve efficiency during cardiac ablation procedures.

Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.

Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.

Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for AFib patients? 

Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.

The new gene therapy candidate is now one step closer to being approved by the FDA.